DiaMedica Therapeutics DMAC
NASDAQ DMAC
$8.35 +0.08 (+0.97%)
At close: Oct 1, 2026 · 4:00 PM EDT

DiaMedica Therapeutics (DMAC) Selling, General & Administrative (2018 - 2026)

Updated

DiaMedica Therapeutics (DMAC) reported Selling, General & Administrative of $2.35 million for Q2 2026, up 7.3% from $2.19 million a year earlier but down 6.0% from the prior quarter.

Analysis

DiaMedica Therapeutics (DMAC) Selling, General & Administrative (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, DiaMedica Therapeutics' Selling, General & Administrative came in at $9.95 million, up 16.8% year-over-year; for FY2025, it was $9.78 million, up 28.3% from FY2024.

  • Selling, General & Administrative has a five-year compound annual growth rate of 16.8% (FY2020 to FY2025).
  • By year, Selling, General & Administrative came in at $7.62 million in FY2024 (-6.5%), $8.16 million in FY2023 (+32.4%), $6.16 million in FY2022 (+26.2%) and $4.88 million in FY2021 (+8.6%).
  • Five-year quarterly Selling, General & Administrative spans a low of $1.08 million in Q3 2021 and a high of $2.6 million in Q3 2025.
  • Year over year, Selling, General & Administrative has now increased in each of the last six quarters, with growth averaging 14.0% over the last eight quarters.
  • The high point for year-over-year Selling, General & Administrative in five years was Q2 2023 (growth of 56.0%); the low point was Q2 2024 (a decline of 22.2%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $2.5 million (Q1 2026), $2.51 million (Q4 2025) and $2.6 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 6.43 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.63 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.90 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -3.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -5.65 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.75 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.92 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 3.41 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 582.20 Mn
10 DiaMedica Therapeutics 445.97 Mn 445.97 Mn - 2.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.35 Mn
Mar 31, 2026 2.50 Mn
Dec 31, 2025 2.51 Mn
Sep 30, 2025 2.60 Mn
Jun 30, 2025 2.19 Mn
Mar 31, 2025 2.49 Mn
Dec 31, 2024 1.95 Mn
Sep 30, 2024 1.90 Mn
Jun 30, 2024 1.71 Mn
Mar 31, 2024 2.07 Mn
Dec 31, 2023 2.17 Mn
Sep 30, 2023 1.89 Mn
Jun 30, 2023 2.20 Mn
Mar 31, 2023 1.90 Mn
Dec 31, 2022 1.70 Mn
Sep 30, 2022 1.49 Mn
Jun 30, 2022 1.41 Mn
Mar 31, 2022 1.56 Mn
Dec 31, 2021 1.38 Mn
Sep 30, 2021 1.08 Mn
API Access

DiaMedica Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=DMAC&period=max&api_key=YOUR_API_KEY